Filing status
- Accounts due
- 30 September 2023
- Last accounts
- 31 December 2021
- Conf. stmt due
- 19 December 2025
- Last conf. stmt
- 5 December 2024
Nektar Therapeutics UK Limited
- Incorporated
- 5 December 1994 (31 years)
- Industry
- Manufacture of other inorganic basic chemicals (20130) Manufacture of other organic basic chemicals (20140)Manufacture of basic pharmaceutical products (21100)Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Mark Wilson
- Owned by
- Nektar Therapeutics
- Accounts type
- Full
- Region
- Greater London
- Address
- 80 Coleman StreetLondonEC2R 5BJ
Charges
- Total
- 1
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 1
Officers 1 active
Officer details are public data from the Companies House register.
Wilson, Mark
Director · Appointed 17 August 2020
American
Born March 1971 (55)
Officer history (32 former)
12 December 2023
17 April 2023
Resigned Thomsen, Jillian as Director
15 July 2022
Resigned Labrucherie, Gil as Director
15 July 2022
Resigned Labrucherie, Gil as Secretary
17 August 2020
Resigned Difonzo, Carlo as Director
17 August 2020
Appointed Wilson, Mark as Director
23 December 2013
23 December 2013
1 October 2009
Resigned Robin, Howard as Director
11 September 2009
25 March 2009
3 March 2008
5 February 2008
Appointed Thomsen, Jillian as Director
5 February 2008
Appointed Difonzo, Carlo as Director
16 January 2008
Resigned Clark, Andrew Reginald as Secretary
16 January 2008
Appointed Labrucherie, Gil as Secretary
16 January 2008
Resigned Searcy, Christopher, Dr as Director
16 January 2008
Resigned Johnston, David as Director
16 January 2008
Appointed Robin, Howard as Director
16 January 2008
Resigned Clark, Andrew, Dr as Director
16 January 2008
Appointed Labrucherie, Gil as Director
20 December 2006
Appointed Clark, Andrew Reginald as Secretary
30 June 2006
30 June 2006
5 April 2006
Appointed Johnston, David as Director
17 March 2006
Resigned Gill, Ajit Singh as Director
6 March 2006
Resigned Bansal, Ajay as Director
11 February 2004
Resigned Makes, Brigid Ann as Director
11 February 2004
Appointed Bansal, Ajay as Director
23 June 2003
Appointed Clark, Andrew, Dr as Director
17 April 2003
17 April 2003
17 April 2003
31 August 2002
31 August 2002
31 August 2002
31 August 2002
12 April 2001
21 March 2001
Appointed Gill, Ajit Singh as Director
21 March 2001
Resigned Hanna, Mazen, Dr as Director
21 March 2001
Appointed Makes, Brigid Ann as Director
21 March 2001
Appointed Searcy, Christopher, Dr as Director
1 November 1999
22 July 1999
22 July 1999
8 June 1999
16 April 1999
16 April 1999
3 April 1995
3 April 1995
3 April 1995
Appointed Hanna, Mazen, Dr as Director
3 April 1995
3 April 1995
3 April 1995
Resigned Johnson, Craig Laurence as Director
3 April 1995
3 April 1995
15 December 1994
Appointed Johnson, Craig Laurence as Director
15 December 1994
15 December 1994
15 December 1994
15 December 1994
15 December 1994
5 December 1994
5 December 1994
5 December 1994
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Nektar Therapeutics
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 2903970
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 3 July 2025 | Confirmation statement with no updates | 5 December 2024 | ||
| 2 July 2025 | Confirmation statement with no updates | 5 December 2023 | ||
| 26 June 2025 | Termination of appointment of a secretary | |||
| 28 April 2025 | Restoration by order of the court | |||
| 28 May 2024 | Final Gazette dissolved via voluntary strike-off |
Some other companies at this address
Other companies in this industry
Chester
Cardiff
Thornaby
Nr Arundel
Bracknell
Chester
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →